As of 2025-10-23, the Relative Valuation of Inozyme Pharma Inc (INZY) is (4.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.00 USD, the upside of Inozyme Pharma Inc based on Relative Valuation is -205.4%.
The range of the Relative Valuation is (3.37) - (5.06) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 2.0x - 3.1x | 2.6x |
| Fair Price | (3.37) - (5.06) | (4.22) |
| Upside | -184.3% - -226.5% | -205.4% |
| Date | P/E |